Ace 2 inhibition
Pro Research Analysisby 
Searched over 200M research papers
ACE2 Inhibition: Implications and Insights
Introduction to ACE2 and Its Role in the Renin-Angiotensin System
Angiotensin-converting enzyme 2 (ACE2) is a critical component of the renin-angiotensin system (RAS), which regulates blood pressure and fluid balance. ACE2 degrades angiotensin II (Ang II) into angiotensin-(1-7) [Ang-(1-7)], a peptide with vasodilatory and anti-inflammatory properties Tikellis2008Guy2003. This function positions ACE2 as a significant modulator in cardiovascular and renal health.
ACE2 Inhibition and Diabetic Nephropathy
Impact on Renal Function
Research has shown that ACE2 expression is significantly altered in diabetic kidneys, affecting the progression of kidney disease and the efficacy of ACE inhibitors. In diabetic mice, ACE2 inhibition with MLN-4760 exacerbated albuminuria and increased blood pressure, indicating worsened renal injury Tikellis2008Soler2007. Conversely, ACE2 deficiency reduced renal hypertrophy and fibrogenesis, suggesting a complex role of ACE2 in diabetic nephropathy .
Comparative Studies with ACE Inhibition
Studies comparing ACE2 overexpression and ACE inhibition in diabetic nephropathy models revealed that both strategies offer renoprotective effects. ACE2 overexpression reduced blood pressure, urinary albumin excretion, and oxidative stress, similar to the effects of ACE inhibitors . However, combining ACE2 overexpression with ACE inhibition did not provide additional benefits, highlighting the potential redundancy in their protective mechanisms .
Structural Insights and Specificity of ACE2 Inhibitors
Active Site and Inhibition Mechanisms
The structural differences between ACE and ACE2, particularly in their ligand-binding pockets, explain the specificity of ACE2 inhibitors. Classical ACE inhibitors like lisinopril do not bind to ACE2 due to these structural variations . Novel peptide inhibitors, such as DX600, have been identified to specifically inhibit ACE2 without affecting ACE activity, providing tools to study ACE2's role in vivo .
Chloride Dependence
ACE2 activity is also influenced by chloride ions, with substrate-specific effects. Chloride ions activate the hydrolysis of angiotensin I but inhibit the cleavage of angiotensin II, suggesting a nuanced regulatory mechanism .
ACE2 Inhibition and COVID-19
Viral Entry and Therapeutic Strategies
ACE2 serves as the entry receptor for SARS-CoV-2, the virus responsible for COVID-19. Inhibiting ACE2 to prevent viral entry has been proposed, but this approach may exacerbate lung and cardiovascular issues due to reduced Ang-(1-7) levels . Instead, using ACE2 soluble analogs or Ang-(1-7) agonists, combined with convalescent plasma, has been suggested to neutralize the virus while preserving ACE2's protective functions .
Molecular Dynamics and Inhibitor Effects
Molecular dynamics simulations have shown that ACE2 inhibitors like MLN-4760 can alter the conformational properties of ACE2, potentially affecting its interaction with the SARS-CoV-2 spike protein. This insight is crucial for designing inhibitors that can block viral entry without compromising ACE2's beneficial effects .
Conclusion
ACE2 plays a multifaceted role in cardiovascular and renal health, as well as in the pathogenesis of COVID-19. While ACE2 inhibition can offer insights into its function, it also presents challenges, particularly in the context of diabetic nephropathy and viral infections. Future therapeutic strategies should aim to balance the inhibition of harmful pathways while preserving or enhancing ACE2's protective effects.
Sources and full results
Most relevant research papers on this topic